849 related articles for article (PubMed ID: 18449891)
1. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
2. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
Zhu W; Shan X; Wang T; Shu Y; Liu P
Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574
[TBL] [Abstract][Full Text] [Related]
3. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.
Zhu W; Zhu D; Lu S; Wang T; Wang J; Jiang B; Shu Y; Liu P
Med Oncol; 2012 Mar; 29(1):384-91. PubMed ID: 21258880
[TBL] [Abstract][Full Text] [Related]
4. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
[TBL] [Abstract][Full Text] [Related]
5. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256
[TBL] [Abstract][Full Text] [Related]
6. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
[TBL] [Abstract][Full Text] [Related]
8. Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2.
Zhuang M; Shi Q; Zhang X; Ding Y; Shan L; Shan X; Qian J; Zhou X; Huang Z; Zhu W; Ding Y; Cheng W; Liu P; Shu Y
Tumour Biol; 2015 Apr; 36(4):2737-45. PubMed ID: 25492481
[TBL] [Abstract][Full Text] [Related]
9. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway.
Qiu L; Ma Z; Li X; Deng Y; Duan G; Zhao LE; Xu X; Xiao L; Liu H; Zhu Z; Chen H
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1202-1214. PubMed ID: 33079995
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
11. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.
Lian W; Zhang L; Yang L; Chen W
Apoptosis; 2017 Jul; 22(7):933-941. PubMed ID: 28439677
[TBL] [Abstract][Full Text] [Related]
12. Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells.
Du J; Shi Y; Pan Y; Jin X; Liu C; Liu N; Han Q; Lu Y; Qiao T; Fan D
Cancer Biol Ther; 2005 Feb; 4(2):242-7. PubMed ID: 15846068
[TBL] [Abstract][Full Text] [Related]
13. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
Hu J; Fang Y; Cao Y; Qin R; Chen Q
Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of drug sensitivity of multidrug-resistant SGC7901/VCR human gastric cancer cells by bax gene transduction.
Zhao Y; Xiao B; Chen B; Qiao T; Fan D
Chin Med J (Engl); 2000 Nov; 113(11):977-80. PubMed ID: 11776130
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2.
Wang P; Li Z; Liu H; Zhou D; Fu A; Zhang E
Biochem Biophys Res Commun; 2016 Oct; 479(1):91-6. PubMed ID: 27622325
[TBL] [Abstract][Full Text] [Related]
16. Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes.
Wang Y; Liu L; Liu X; Zhang H; Liu J; Feng B; Shang Y; Zhou L; Wu K; Nie Y; Zhang H; Fan D
Tumour Biol; 2013 Aug; 34(4):2205-14. PubMed ID: 23564482
[TBL] [Abstract][Full Text] [Related]
17. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
[TBL] [Abstract][Full Text] [Related]
18. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
[TBL] [Abstract][Full Text] [Related]
19. miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells.
Xu K; Liang X; Cui D; Wu Y; Shi W; Liu J
Mol Carcinog; 2013 Jan; 52(1):70-8. PubMed ID: 22121083
[TBL] [Abstract][Full Text] [Related]
20. Regulation of drug resistance and metastasis of gastric cancer cells via the microRNA647-ANK2 axis.
Cao W; Wei W; Zhan Z; Xie D; Xie Y; Xiao Q
Int J Mol Med; 2018 Apr; 41(4):1958-1966. PubMed ID: 29328428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
